Enzon Pharmaceuticals, Inc. (ENZND)
4.03
-1.85
(-31.46%)
USD |
OTCM |
Mar 25, 16:00
Enzon Pharmaceuticals Total Liabilities (Quarterly) : 0.731M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 504.66M |
| Curis, Inc. | 15.02M |
| Windtree Therapeutics, Inc. | 27.58M |
| Halozyme Therapeutics, Inc. | 2.665B |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 42.81M |
| Shareholders Equity (Quarterly) | 42.08M |
| Current Ratio | 58.57 |